Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
caffeine + diclofenac + paracetamol
- Development stage
- Unknown
- Lead developer
- Signature Phytochemical Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tekomol is a fixed-dose combination analgesic, antipyretic, and anti-inflammatory medication containing paracetamol (acetaminophen), diclofenac sodium, and caffeine. Developed and manufactured by Hab Pharmaceuticals and Research and its subsidiary Signature Phytochemical Industries, Tekomol is designed to provide rapid and effective relief from mild to moderate pain, fever, and inflammation. Paracetamol and diclofenac sodium act as non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing the synthesis of inflammatory prostaglandins. Caffeine acts as a central nervous system stimulant and non-selective adenosine receptor antagonist (targeting ADORA1 and ADORA2A), which enhances the analgesic efficacy of the NSAID components. Tekomol is primarily indicated for the management of headaches, musculoskeletal pain, joint pain, toothaches, and fever.
- Brand names
- Diclowell ForteGebedol PlusReality ExtraTekomol
- Other names
- caffeine + diclofenac sodium + paracetamoldiclofenac + paracetamol + caffeinediclofenac sodium + paracetamol + caffeine
02
Targets
ADORA2A (Adenosine A₂A Receptor)ADORA3 (Adenosine A3 receptor)PGHS-1 (Prostaglandin G/H Synthase 1)ADORA2B (Adenosine A2B receptor)ADORA1 (Adenosine receptor A1 subtype)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on caffeine + diclofenac + paracetamol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on caffeine + diclofenac + paracetamol.